Cluster Randomized Controlled Trial: Clinical and Cost-Effectiveness of a System of Longer-Term Stroke Care by Forster, A et al.
2212
The high prevalence and diversity of longer-term problems experienced by patients with stroke and their carers has 
long been recognized,1 but they remain poorly addressed by 
existing services.2 Postdischarge contact with therapy ser-
vices is associated with improved outcomes.3,4 However, these 
interventions are generally time limited and have little effect 
on psychosocial outcome. National guidelines5 acknowledge 
that stroke should be regarded as a long-term condition, and 
the role of a Stroke Care Coordinator (SCC) to facilitate 
inputs for community-based patients with stroke and their 
families after initial (usually hospital-based) treatment is a 
recommended policy.6,7 However, procedures and processes 
of this role are unevenly developed, and there has been no 
robust evaluation.
Using the Medical Research Council framework for the 
development and evaluation of complex interventions,8 incor-
porating systematic reviews, qualitative exploration, and inter-
vention modeling, we developed an evidence-based system 
of care (longer-term stroke [LoTS] care) that aimed to meet 
the longer-term needs of patients with stroke and their carers 
living at home. The system of care incorporates a structured 
assessment focused on patient- and carer-centered problems 
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and is linked to evidenced-based treatment algorithms and a 
goal and action planner based on a problem-solving approach. 
We report findings from a trial evaluation of the LoTS care 
system of care.
Methods
Study Design and Participants
The trial was a pragmatic cluster randomized controlled trial of the 
clinical and cost-effectiveness of the LoTS care system of care deliv-
ered by community-based SCCs compared with SCC usual practice. 
Trial procedures were informed by a survey of SCCs.9 The methods 
have been reported in detail elsewhere10 and undertaken after appro-
priate ethical approval.
A SCC was eligible if the following criteria were fulfilled: a reg-
istered healthcare professional with documented experience in stroke 
care; undertaking a community-based coordinating role for patients 
with stroke; in contact with patients and coordinating a range of care 
inputs on behalf of the patient or carer (eg, signposting, carrying out 
assessments); receiving referrals from an acute stroke service that in-
cluded a stroke unit fulfilling the Royal College of Physicians audit 
definition.11 A SCC was classified as working in a team if they partici-
pated in community multidisciplinary team meetings. Eligibility of the 
SCC service was confirmed before randomization by completion of a 
questionnaire and semistructured interview describing the service and 
client group (these were repeated midway through recruitment and 
after 12-month follow-up). This information was also used for stratifi-
cation to provide context for trial implementation and monitor any po-
tential contamination or confounding between the 2 arms of the trial.
In keeping with the pragmatic trial design, patient eligibility crite-
ria were broad. Patients were eligible if they had a confirmed primary 
diagnosis of a new stroke, were referred to an SCC on discharge home 
or within 6 weeks of stroke (if not admitted to hospital), and were still 
waiting for their first community SCC assessment. Patients were ex-
cluded if they had a planned permanent admission to, or were already 
resident in, a nursing or residential care home; or their main require-
ment was palliative care. Carers were eligible if a participating patient 
identified them as the main informal carer who provided practical sup-
port at least once per week. Written informed consent for baseline and 
follow-up assessments was obtained from patients (and carers if ap-
propriate) before baseline assessment. In the event that a patient lacked 
capacity to consent, the patient’s family member, carer, or friend was 
asked to act as the consultee and provide consultee declaration.
Randomization and Masking
The unit of randomization was the SCC service randomized on a 1:1 
basis to either the control or the intervention group. Randomization 
was stratified by the quality of the local stroke unit (National Sentinel 
Stroke Audit median score of 65 based on 2006 data)11; annual num-
ber of referrals to the SCC service; SCCs working alone or within a 
community team; and by geographical area. A method of obtaining a 
balanced randomization from these covariates based on a method by 
Carter and Hood12 was used.
Control
Patients in services allocated to the control group received the SCC 
service in accord with the existing local policies and practices. After 
randomization, the control group SCCs were asked to complete time 
logs for all patients documenting the number and duration of contacts, 
and the time spent coordinating actions, note writing, and discussing 
the patient in multidisciplinary team meetings if these took place.
Intervention
The SCC services allocated to the intervention group provided care 
according to the LoTS care system of care. This comprises a frame-
work of 16 structured assessment questions (linked to evidence-based 
treatment algorithms and reference guides) that directly relate to lon-
ger-term stroke problems previously identified by patients with stroke 
and their carers13,14 and related prompts provided in a care plan. The 
care plan also includes a goal and action planner to be completed after 
each contact (patients and carers). This system of care was supported 
by a training program and detailed manual, underpinned by a prob-
lem-solving approach (Table 1; details are provided in the online-only 
Data Supplement). The number of contacts was not specified but de-
termined by the SCCs’ usual practice and patient need. The key prin-
ciples being that all assessment questions were asked and that goals 
and action plans were identified and reviewed with service responses 
being provided as appropriate within the context of the services avail-
able and the patient’s own environment.15
Recruitment was opened 4 to 6 months after the initial training 
meeting, providing sufficient time for the implementation of the sys-
tem of care into standard practice. Compliance with the intervention 
was predefined by the trial team as including at least 12 (75%) of the 
16 assessment areas recorded as discussed on the care plan during the 
first patient contact.
Procedures
The trial used existing SCC referral pathways as determined during 
site set-up. The majority of patients were referred to an SCC service 
through a predischarge inpatient referral. Recruitment of trial partici-
pants was by independent research staff blinded as to whether they 
were recruiting within a control or an intervention service, and the 
SCCs were unaware which of their patients had consented to partici-
pate. This trial design reduced the potential for selection bias from 
Table 1. Components of the Longer-Term Stroke Care System of Care
Care plan containing a structured assessment with a goal and action planner for each contact
 Patient: 16 assessment questions (15 specific+other)
 Carer: 13 assessment questions (12 specific+other)
An optional checklist indicating the content of the assessment to be sent to patients beforehand
A manual containing reference guides including robust evidence-based treatment algorithms linked to the assessment questions (15 patient-specific and 1 carer-
specific), a frequency table of longer-term problems after stroke, service directory, and recommended assessment scales
National information about services available for patients after stroke (eg, Disabled Holiday Directory, Age Concern); the SCCs were asked to develop a resource 
inventory of local services
Training in use of the system of care
 Training day 1: details of the system of care, guidance on problem solving techniques, principles of the intervention
 Period of implementation of the system of care (≈1 mo)
 Training day 2: review of use of the system of care and problem solving, training in specific areas (eg, pain)
 Provision of a CD of the training presentations
SCC indicates Stroke Care Coordinator.
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differential recruitment16 inherent if the SCCs were responsible for 
patient identification and minimized likelihood of altering of SCCs’ 
clinical activity for trial participants.
The research staff collected anonymous screening data (demo-
graphic data and modified Rankin Scale score17) for all patients 
referred to a participating SCC. For recruited patients, researchers 
collected baseline demographic data, including assessment of cogni-
tion (6-Item Cognitive Impairment Test),18 language ability, prestroke 
disability (Barthel index19), and the 6 items that allow calculation of 
the Edinburgh stroke case mix adjuster.20
Consistent with a patient-centered model of stroke recovery in 
which adjustment to activity restrictions and participation are re-
garded as the critical issues, the primary outcome was an assessment 
of psychological well-being measured by patient reported General 
Health Questionnaire-12 (GHQ-12)21 at 6 months after recruitment, 
with a secondary outcome at 12 months (for the GHQ-12 higher 
scores equate to poorer outcomes). This outcome measure is short 
and easy to complete, consistent with the high prevalence of psycho-
logical symptoms after stroke,13 and that psychological problems be-
come more prevalent with time.22 Other patient reported secondary 
outcome measures were Frenchay Activities Index (extended activi-
ties of daily living),23 Barthel Index (activities of daily living),19 and 
European Quality of Life-5 Dimensions (health state).24,25 Patients 
also completed the Longer-term Unmet Needs after Stroke question-
naire (unmet stroke related needs).26 Carer-reported outcomes includ-
ed GHQ-12 and Carer Burden Scale (assessment of carer burden).27 A 
Client Service Receipt Inventory (CSRI28,29; use of services prestroke 
and postdischarge) was completed to inform the economic evalua-
tion. The research staff recorded deaths, emergency outpatient treat-
ment, and hospital admissions at 6 and 12 months post recruitment.
Patient- and carer-reported outcomes were assessed in baseline 
questionnaires and via postal questionnaires at 6 and 12 months post 
recruitment. This was supported by postal and telephone reminders 
if questionnaires were not returned within 2 weeks. If necessary (af-
ter postal and telephone reminders), patients were contacted by tele-
phone to complete the primary outcome measure (GHQ-12).
Process data were collected for trial patients after the end of 12 
month follow-up so as not to unblind the SCC to trial patients. Time 
logs were collected for patients in control services. In intervention 
services, data on the use of the structured assessment and goal and 
action planner (including time taken) were collected by researchers 
transcribing the appropriate information from the care plans at site.
Sample Size
The sample size calculations, based on the primary outcome measure 
GHQ-12 at 6 months, indicated that recruitment of 800 patients from 
40 services would provide 90% power at 5% significance level to 
detect a clinically relevant difference of 2.5 GHQ-12 points (SD, 7), 
as reported in a previous study.30 This sample size accounted for an 
estimated 25% loss to follow-up and clustering: the inflation factor 
of 1.95 was derived from a maximum cluster size of 20 and an intra-
cluster correlation coefficient of no >0.05.31 Losses to follow-up were 
anticipated to increase over time, and interpretation and credibility 
of results are difficult if losses exceed 30%; therefore, follow-up was 
limited to 12 months post recruitment and the primary outcome was 
defined as 6 months.
We were able to identify 32 SCC services which were eligible, 
willing to participate and provide a principal investigator, and these 
were randomized. We planned that each service would recruit 25 
patients for 18 months, to provide power of 88%, assuming equal 
cluster size and no >25% loss to follow-up. To minimize unequal re-
cruitment to clusters, the maximum number of patients per service 
was capped at 45.
Statistical Methods
Statistical analyses were conducted on the intention to treat popula-
tion for both primary and secondary analyses. The intention to treat 
population was defined as all patients registered for active follow-up 
regardless of noncompliance with the intervention. A per-protocol 
analysis was also undertaken where major protocol violators and pa-
tients not receiving care from SCC were excluded from the analy-
sis. All statistical testing was performed at a 2-sided 5% significance 
level. Analyses were completed using SAS software version 9.2 (SAS 
Institute Inc, Cary, NC).
Primary and secondary outcomes were compared between the 
control and intervention groups using a 2-level multilevel model, 
with patients nested within stroke services. The models were ad-
justed for the patient-level covariates (level 1): baseline Barthel 
Index (prestroke and poststroke), sex, age, living circumstances (liv-
ing alone versus with carer), stroke severity reflected by speech and 
language impairment (normal/impaired), baseline 6-Item Cognitive 
Impairment Test score (normal/impaired cognitive function), and 
patient baseline score for the outcome measure; and the following 
stroke unit-level covariates (level 2): quality of stroke unit (National 
Sentinel Stroke Audit score), referral rate, and SCCs working alone 
versus within a community multidisciplinary team.
Sensitivity analyses were undertaken to test the robustness of 
analysis assumptions, including patients who died by assuming worst 
possible GHQ-12 outcome; only including patients returning postal 
questionnaires at 6 months (excluding patients who provided primary 
outcome via telephone call); repeating the analysis without proxy 
responses; using data collected at 12 months for patients who did 
not return questionnaires at 6 months, and assuming data missing at 
random using multiple imputation.
Details of patient deaths and hospital readmissions, unmet needs, 
carer deaths, any serious adverse events, and related and unexpected 
serious adverse events were reported for each treatment group. The 
relationships between adjusted primary outcome and completion of 
time logs in control or compliance with care plans in intervention 
were explored graphically.
Economic Evaluation
The prospective economic evaluation was from both health/social care 
and societal perspectives linking costs (including SCC inputs) with 
the GHQ-12 and quality-adjusted life years (QALY) derived from 
European Quality of Life-5 Dimensions. The primary end point was 6 
months, but we also examined findings at 12 months and over the year 
(full details are provided in the online-only Data Supplement). Unit 
costs (£, 2010/11 prices) were attached to individual-level resource 
use quantities (measured retrospectively by self-report) to calculate 
total costs per participant. Costs are shown in English pounds sterling 
(£) and can be converted to US dollars using the rate £1=$1.43, based 
on 2011 purchasing power parities, which equalize the purchasing 
power of the currencies.32 Discounting was unnecessary for the study 
time frame. We compared costs and QALY gains using multilevel 
models with baseline covariates, calculating incremental cost-effec-
tiveness ratios only where 1 intervention showed higher costs and 
better outcomes. We examined the intervention’s probability of cost-
effectiveness by constructing cost-effectiveness acceptability curves 
(5000 bootstrap replications) for threshold ranges of £0 to £2000 for 
GHQ-12 point gains and £0 to £50 000 for QALY gains.
Results
The CONSORT diagram is shown in Figure. Thirty-two stroke 
service clusters were randomized (75% of these involved were 
team-based rather than individual SCCs); 29 clusters recruited 
participants (14 control and 15 intervention clusters). Of the 
3 services unable to participate, 1 service changed its refer-
ral process after randomization; in 1 service, the SCC was 
absent because of long-term sickness; and in 1 service, we 
were unable to identify a researcher to undertake recruitment.
Between July 1, 2009 and March 31, 2011, 2488 patients 
were screened; 800 patients (56.3% [800/1420] of eligible 
patients) and 208 carers were registered into the trial (399 
patients/100 carers in the control group; 401 patients/108 car-
ers in the intervention group). Of these, 66 of 800 (8.2%) 
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were by consultee declaration. The study was completed after 
receipt of the 12-month assessments of the final patients in 
May 2012. The baseline characteristics of the patients and 
carers were balanced across the control and intervention 
groups other than there were more patients with higher edu-
cation and fewer with language or cognitive impairments in 
the control group and a difference in length of inpatient stay 
which was shorter in the control arm. Language and cogni-
tive impairment were accounted for in the statistical model-
ing. Patient baseline characteristics are shown in Table 2, and 
carer baseline characteristics are shown in the online-only 
Data Supplement.
Of patients registered to the trial, 314 of 399 (78.7%) 
patients in the control group and 318 of 401 (79.3%) patients in 
the intervention group received the SCC service. Reasons for 
not receiving the service included SCC not receiving a refer-
ral; patient declining; patient death or patient not contactable. 
Response rates for patient reported outcomes at 6 months were 
75.2% (300/399) in control and 77.3% (310/401) in interven-
tion and at 12 months, 67.2% (268/399) in the control and 
Figure. Cluster allocation and patient flow by treatment arm. PI indicates principal investigator.
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70.1% (281/401) in the intervention group. Response rates for 
carer reported outcomes are provided in the online-only Data 
Supplement.
There was no evidence of a statistically significant differ-
ence for the primary end point. The adjusted GHQ-12 mean 
score at 6 months was 14.9 (SE, 0.6) points for the control 
group and 15.5 (SE, 0.6) points for the intervention group, 
with a difference of −0.6 points (95% confidence interval, −1.8 
to 0.7), P value of 0.394, and adjusted intracluster correlation 
coefficients of 0.013 in the control group and 0.025 in the inter-
vention group. Analyses of secondary patient end points also 
indicated no evidence of statistically significant differences in 
the Barthel Index, European Quality of Life-5 Dimensions, 
Frenchay Activities Index at 6 and 12 months, or the GHQ-12 
at 12 months (Table 3; unadjusted patient questionnaire scores 
are provided in the online-only Data Supplement). The num-
ber and types of unmet needs reported (Longer-term Unmet 
Needs after Stroke questionnaire), deaths, hospital readmis-
sions, institutionalization, and treatment on an emergency out-
patient basis were similar for both groups (details are provided 
in the online-only Data Supplement). Between-group compar-
isons of the adjusted scores for the carer reported GHQ-12 and 
Carer Burden Scale at 6 and 12 months indicated no evidence 
of statistical differences for these outcomes (Table 3).
Results of per-protocol analyses (conducted for all patient 
and carer end points) and sensitivity analyses (conducted on 
the primary end point) were consistent with results of the 
intention to treat analyses with no evidence of statistical dif-
ferences between treatment groups (Table 4).
SCCs completed care plans within the trial period for 280 
of 401 (69.8%) patients in the intervention group and time 
logs for 207 of 399 (51.9%) patients in the control group. In 
the intervention group, there were 269 of 280 (96.1%) care 
plans that met the definition of compliance with on average 15 
of 16 (93.8%) of assessment areas asked at first contact. From 
the care plan and time log records, the median number of 
SCC patient assessment contacts was 2 (range, 1–6) contacts 
in the intervention group and 2 (range 1–7) contacts in the 
control group. No linear trend was observed between percent-
age of compliant care plans or percentage of completed time 
logs and adjusted mean primary outcome for intervention and 
control services respectively (Figures and further information 
presented in the online-only Data Supplement). Review of 
Table 2. Patient Baseline Demographic and Clinical Details
Patient Control, n=399 Intervention, n=401
Age, mean (SD) 72.5 (12.84) 70.9 (13.18)
Sex, male, n (%) 218 (54.6) 215 (53.6)
Ethnicity, white, n (%) 389 (97.5) 388 (96.8)
Formal education, n (%) 383 (96.0) 380 (94.8)
  Left education at ≤16, n (%) 282 (73.6) 319 (83.9)
Cerebral infarction, n (%) 343 (86.0) 341 (85.0)
Left hemiparesis, n (%) 179 (44.9) 178 (44.4)
Normal language ability, n (%) 323 (81.0) 295 (73.6)
Normal cognitive function (6CIT), n (%) 267 (66.9) 229 (57.1)
In-hospital stay, d, mean (SD)* 29.5 (34.9) 38.9 (44.4)
Living alone post stroke, n (%) 138 (34.6) 118 (29.4)
6CIT indicates 6-Item Cognitive Impairment Test.
*Data for patients with in-hospital stay (control, n=389; intervention, n=391).
Table 3. Primary and Secondary Outcomes: Patient- and Carer-Adjusted Questionnaire Scores at 6 and 12 mo
Questionnaire Control Mean (SE), n
Intervention  
Mean (SE), n
Difference  
(SE)
95% CI of the 
Difference P Value 
Adjusted ICC
Control Intervention
Patient adjusted questionnaire scores
  6 mo
   GHQ-12 14.9 (0.60), 300 15.5 (0.60), 310 −0.6 (0.65)  −1.8 to 0.7 0.394 0.013 0.025
   Barthel Index 15.8 (0.33), 296 15.3 (0.28), 307 0.5 (0.33) −0.2 to 1.1 0.133 0.022 0
   EQ-5D 0.58 (0.025), 288 0.55 (0.022), 301 0.03 (0.025) −0.02 to 0.08 0.252 0.014 0.059
   FAI 19.0 (0.76), 293 18.0 (0.76), 304 1.0 (0.80) −0.6 to 2.5 0.229 0 0.014
  12 mo
   GHQ-12 14.4 (0.58), 268 13.9 (0.72), 281 0.5 (0.73) −0.9 to 2.0 0.454 0 0.063
   Barthel Index 15.6 (0.36), 266 15.4 (0.30), 282 0.2 (0.37) −0.5 to 0.9 0.585 0.049 0.023
   EQ-5D 0.56 (0.030), 259 0.51 (0.028), 270 0.05 (0.033) −0.02 to 0.11 0.167 0.050 0.044
   FAI 20.2 (0.78), 266 18.7 (0.84), 281 1.5 (0.87) −0.2 to 3.2 0.078 0 0.025
Carer adjusted questionnaire scores
  6 mo
  GHQ-12 12.5 (0.69), 82 14.2 (0.79), 80 −1.7 (0.91) −3.5 to 0.1 0.061 0 0
  CBS 44.5 (2.19), 81 48.4 (1.80), 80 −3.9 (2.51) −8.8 to 1.1 0.125 0.055 0
  12 mo
   GHQ-12 13.5 (1.11), 71 13.9 (0.85), 73 −0.4 (1.26) −2.9 to 2.1 0.747 0.255 0
   CBS 43.9 (2.85), 71 48.7 (2.11), 72 −4.8 (3.17) −11.1 to 1.5 0.132 0.137 0
CBS indicates Carer Burden Scale; CI, confidence interval; EQ-5D, European Quality of Life-5 Dimensions; FAI, Frenchay Activities Index; GHQ-12, 12-item General 
Health Questionnaire; and ICC, intracluster correlation coefficient.
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the semistructured interviews indicated that no control SCCs 
used a similar structured assessment tool or had access to an 
evidenced-based treatment manual.
For the economic evaluation, 564 (70.5%) participants 
had the combination of complete cost and European Quality 
of Life-5 Dimensions data and 589 (73.6%) had complete cost 
and GHQ-12 data. Costs of SCC inputs were similar in both 
groups (mean difference, £42; 95% confidence interval, −30 to 
116; Table 5; mean includes zero costs where SCC inputs were 
not received). There were no differences in mean total health 
and social care costs (Table 5). Informal care costs increased 
after baseline and were significantly higher in the intervention 
group at 6 months, 12 months, and over the year. Although 
informal care costs fell between the 6- and 12-month assess-
ments in the control group, they increased over the same period 
in the intervention group. This is reflected in higher total soci-
etal costs in the intervention group at 6 and 12 months and 
over the year (mean difference at 6 months, £1163; 95% con-
fidence interval, 56–3271; Table 5). QALY gains were similar 
(Table 5). Imputing missing health and social care costs and 
QALYs at 6 months did not alter conclusions about cost or 
QALY differences. Incremental cost-effectiveness ratios were 
unnecessary because no cost–outcome combination suggested 
statistically significant between-group increases in both costs 
and outcomes. At 6 months, the intervention had low probabili-
ties of cost effectiveness from both perspectives and for both 
outcomes, remaining <0.3 for the threshold ranges examined. 
More details on the economic evaluation are given in the online-
only Data Supplement.
Discussion
The LoTS care trial was a pragmatic, multicenter, cluster ran-
domized, controlled trial of a complex intervention designed to 
provide a structured but individualized care planning process 
that encompassed the range of problems commonly encoun-
tered by people recovering from a stroke and delivered by SCCs 
working in the community. The main finding was no evidence 
of statistically significant differences between the control and 
intervention groups in primary or secondary outcomes in the 
intention to treat and per-protocol analyses, or in the primary 
outcome in sensitivity analyses, and no evidence of cost effec-
tiveness from health and social care and societal perspectives.
Strengths of the Study
The trial followed closely the Medical Research Council 
guidance on the evaluation of a complex intervention. The 
trial recruited 800 patients in 29 services across the United 
Kingdom. This makes it one of the largest stroke rehabilitation 
trials completed to date. The range of disparate geographical 
regions ensured a good representation of different healthcare 
settings optimizing generalizability. The eligibility criteria were 
kept to a minimum, in keeping with the pragmatic trial design, 
to ensure that a stroke patient population representative of refer-
rals to SCCs was recruited, including patients with language 
and cognitive impairment. Of the patients eligible for the trial, 
56% were recruited. Comprehensive screening and recruit-
ment data were collected from all participating services, and 
no evidence for bias in selection procedures was found. The 
75% follow-up rate for patients at 6 months as required for the 
power calculation was achieved. Postal assessment was used 
to maintain unbiased assessment, problematic in cluster trials 
where unblinding of a researcher to 1 participant would inevi-
tably result in unblinding of the whole cluster. The intervention 
documentation (care plan) was so designed that it replaced the 
intervention SCCs’ previous patient documentation and thus 
became embedded in their standard practice. A range of sensi-
tivity analyses were undertaken to test robustness of trial results.
Limitations of the Study
The GHQ12 was selected as an appropriate primary outcome 
measure that was person-centered and reflected the desirable 
outcome of well being after stroke rather than the more narrow 
focus of functional recovery. It is possible that the GHQ12 
was insufficiently sensitive to change to identify outcome 
differences in our study population, and an alternative pri-
mary outcome addressing quality of life may have been more 
appropriate. However, we used a broad range of secondary 
outcomes all of which demonstrated no differences between 
treatment arms.
Table 4. Sensitivity and Per-Protocol Analyses for Primary End Point—Patient-Adjusted GHQ-12 Scores at 6 mo
6 mo Adjusted ICC
Analysis
Control Mean  
(SE), n
Intervention  
Mean (SE), n Difference (SE)
95% CI of the 
Difference P Value Control Intervention
Patients who died (GHQ-12 assigned to be 36) 17.5 (0.67), 325 18.3 (0.61), 342 −0.8 (0.68) −2.1 to 0.6 0.263 0.004 0
Excluding those with primary end point over 
the phone
15.0 (0.62), 294 15.5 (0.60), 308 −0.5 (0.66) −1.8 to 0.8 0.436 0.018 0.027
Excluding proxy responses 14.7 (0.62), 296 15.2 (0.63), 294 −0.5 (0.63) −1.7 to 0.7 0.427 0.009 0.021
Data from 12 mo used for patients who  
did not return their questionnaires at 6 mo
14.9 (0.57), 319 15.7 (0.61), 331 −0.7 (0.64) −2.0 to 0.5 0.251 0.007 0.031
Multiple imputation* 15.4 (0.59), 399 15.9 (0.58), 401 −0.5 (0.59) −1.7 to 0.6 0.370 n/a† n/a†
Per-protocol analysis 14.0 (0.69), 228 14.8 (0.78), 248 −0.8 (0.76) −2.3 to 0.7 0.280 0 0.058
CI indicates confidence interval; GHQ-12, 12-item General Health Questionnaire; ICC, intracluster correlation coefficient; ITT, intention to treat; and n/a, not available.
*Sensitivity analysis accounting for all participants in the ITT population assuming data missing at random was performed using multiple imputation. Information 
based on Edinburgh stroke case mix adjuster, clinical classification of stroke, patient health status (alive, died, or too poorly) and prespecified model covariates were 
used to impute the missing outcomes, and the analysis of primary end point was repeated using the same model as multilevel modeling.
†n/a—unable to obtain ICCs from multiple imputation, as estimates in some of the imputations had ICC=0.
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In designing the trial we were concerned about losses to 
follow-up, which are likely to increase over time and impair 
the interpretation and credibility of results. We therefore lim-
ited follow-up to 12 months post recruitment and defined the 
primary outcome at 6 months. However, it may be that the 
intervention had a beneficial effect for a longer period of time, 
which our assessment schedule would not detect.
Interpretation
Unlike other chronic diseases in which evidenced-based 
guidelines for long-term care management are available (eg, 
heart failure33), there has been little research on comprehen-
sive management systems to optimize outcomes for patients 
with stroke. The need for this is attested by observational stud-
ies that describe longer-term stroke outcomes, for example, 
in a survey of >750 stroke survivors in the United Kingdom 
1 to 5 years after the stroke onset,34 half reported some unmet 
needs. This deficiency in care was identified in the specific rec-
ommendation of the National Stroke Strategy (England)7 and 
other national guidelines35,36 for regular poststroke reviews. 
The LoTS care system of care was designed to address this 
recommendation.
Although the structured assessment was delivered to the 
majority of participants who received the intervention SCC 
service, it is more difficult to assess the extent to which a 
change of practice occurred in relation to the problem-solving 
and goal-setting approaches. The number of patient assess-
ment contacts was comparable with the control services, with 
a median of 2 contacts in both. This reflects the pretrial survey 
and existing SSC service models but may be insufficient con-
tact time to meaningfully review goals and develop a problem-
solving approach. Although all of the reference guides are 
evidence-based, the evidence points to more effective inter-
ventions for certain problems than for others, thereby poten-
tially weakening the overall effectiveness of this complex 
intervention. In addition, some needs may only be success-
fully addressed if appropriate care and treatment are locally 
available for the problems identified. This may be particularly 
relevant in relation to psychological problems.37 This in turn 
impinges on our main outcome measure that assessed psycho-
logical wellbeing.
Future Research
There remains a need to develop, implement, and evaluate 
complex interventions capable of addressing the longer-term 
needs of people recovering from stroke. Regular review of 
these needs is an essential component of a longer-term stroke 
service not only to improve patient care but also to highlight 
gaps in service provision, which require addressing. The het-
erogeneity of stroke survivors, who have a wide range of prob-
lems and unmet needs, indicates that targeted more bespoke 
interventions may be the way forward.
Table 5. Mean Total Costs at Baseline (for the Previous 3 mo), 6 mo (Previous 6 mo), 12 mo (Previous 6 mo), and 
Over the Year (£, 2010/11 Prices); QALY Gains at 6 mo (Since Baseline), 12 mo (Since 6 mo), and Over the Year
Intervention, n=401 Control, n=399 Intervention–Control*
Valid, n Mean SD Valid, n Mean SD
Mean 
Difference 95% CI
P 
Value
SCC inputs, £ 401 277 207 399 239 146 42   −30 to 116 0.258
Total health and social care, £
  Baseline 401 713 2636 398 787 1709 −74  −382 to 234 0.639
  6 mo† 307 3369 4735 295 3171 5942 98  −721 to 917 0.814
  12 mo 283 2408 4161 268 1967 3726 291  −316 to 898 0.347
  1 y† 263 5442 6837 252 4462 6415 706 − 335 to 1748 0.184
Total societal, £
  Baseline 401 2651 4401 398 2296 3661 355  −206 to 917 0.215
  6 mo† 307 11 586 11 981 295 9347 9269 1663     56 to 3271 0.043
  12 mo 283 13 560 22 383 268 7653 9472 4135    618 to 7652 0.021
  1 y† 263 24 450 28 055 252 16 359 15 034 5809  1884 to 9734 0.004
QALY gains
  Baseline utility 381 0.51 0.38 382 0.56 0.34 −0.04 −0.12 to 0.03 0.246
  6 mo 289 0.27 0.15 276 0.29 0.15 −0.004 −0.02 to 0.01 0.436
  12 mo 247 0.28 0.14 238 0.31 0.15 −0.01 −0.03 to 0.01 0.233
  1 y 239 0.56 0.28 228 0.61 0.28 −0.01 −0.04 to 0.02 0.492
Costs are shown in English pounds sterling (£) and can be converted to US dollars using the rate £1=$1.43, based on 2011-purchasing 
power parities, which equalize the purchasing power of the currencies. 6CIT indicates 6-Item Cognitive Impairment Test; CI, confidence 
interval; GHQ12, 12-item General Health Questionnaire; QALY, quality-adjusted life years; and SCC, Stroke Care Coordinator.
*Comparisons of 6 mo, 12 mo, and 1 y costs include covariates for baseline patient Barthel Index (prestroke and poststroke), sex, age, 
living circumstances (living alone vs with carer), stroke severity as represented by speech and language impairment (normal/impaired) and 
6CIT score (normal/impaired), utility score, GHQ12 score, and the relevant cost category. Comparisons of QALY gains include covariates 
for baseline patient Barthel Index (prestroke and poststroke), sex, age, living circumstances (living alone vs with carer), stroke severity as 
represented by speech and language impairment (normal/impaired) and 6CIT score (normal/impaired), utility score, and GHQ12 score.
†Including the cost of SCC input.
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